approval
saveGLEEVEC (IMATINIB MESYLATE) — FDA approval
community read0 votes
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalGLEEVEC (IMATINIB MESYLATE) — FDA approvalMar 1, 2024 · 954d ago
- approvalGLEEVEC (IMATINIB MESYLATE) — FDA approvalAug 19, 2022 · 1514d ago
- approvalGLEEVEC (IMATINIB MESYLATE) — FDA approvalMar 24, 2022 · 1662d ago
- approvalGLEEVEC (IMATINIB MESYLATE) — FDA approvalAug 10, 2020 · 2253d ago
- approvalGLEEVEC (IMATINIB MESYLATE) — FDA approvalAug 10, 2020 · 2253d ago
- approvalGLEEVEC (IMATINIB MESYLATE) — FDA approvalAug 21, 2018 · 2973d ago
- approvalGLEEVEC (IMATINIB MESYLATE) — FDA approvalSep 29, 2017 · 3299d ago
- approvalGLEEVEC (IMATINIB MESYLATE) — FDA approvalSep 6, 2017 · 3322d ago
same company · ±60 days · 6
- approvalinclisiran: LEQVIO (INCLISIRAN SODIUM) — FDA approvalFeb 12, 2026
- approvalinclisiran: LEQVIO (INCLISIRAN SODIUM) — FDA approvalFeb 12, 2026
- approvalasciminib hydrochloride: SCEMBLIX (ASCIMINIB HYDROCHLORIDE) — FDA approvalNov 25, 2025
- approvalRestasis: SANDIMMUNE (CYCLOSPORINE) — FDA approvalMar 6, 2026
- approvalRestasis: SANDIMMUNE (CYCLOSPORINE) — FDA approvalMar 6, 2026
- approvalRestasis: SANDIMMUNE (CYCLOSPORINE) — FDA approvalMar 6, 2026
comments(0)
5-min edit window · permanent after that